




<!doctype html>
<html>
<head><script>(function (w, d, s, l, i) {
 w[l] = w[l] || []; w[l].push({
  'gtm.start':
  new Date().getTime(), event: 'gtm.js'
 }); var f = d.getElementsByTagName(s)[0],
 j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
})(window, document, 'script', 'dataLayerCIT', 'GTM-W6MJHWF');</script>
 <meta charset="utf-8" />
 <meta name="viewport" content="initial-scale=1.0">
 <title>JADENU&#174; (deferasirox) Co-Pay Assistance Program </title>
 <meta name="description" content="Discover if you are eligible for financial and patient support including the JADENU Co-Pay Card and Assistance Program. See full Prescribing &amp; Safety info, including Boxed Warning.">
 <meta name="keywords">

  <link rel="icon" type="image/png" href="../../globalassets/products/favicon.ico" />

 <link href='https://fonts.googleapis.com/css?family=Playfair+Display' rel='stylesheet' type='text/css'>

 
 <link href="../../DigiOne.Oncology.Library/Styles%3Fv=itp02BRoEAc8OFaXP_7l2rp8eSXvY0QlGet4rpckGPI1.css" rel="stylesheet"/>

<link href="../../DigiOne.Theme.Products/Styles%3Fv=WPHSrjZrpVjkfMQxBNkI_TR8XHzEusYIEeD9a7pUVUA1.css" rel="stylesheet"/>

<meta name="google-site-verification" content="Fdi8lIeexJg9xN80-SH2bL3ytU5UesxzKqpGB1pC93s" />

 


<style>
  .primary-brand-color {
color: #18286b;
  }
  .primary-brand-color a {
color: #18286b;
  }
  .primary-brand-color a:hover {
color: #18286b;
opacity: 0.75;
  }
  
  ul.nav li.active > a {
color: #18286b !important;
  }

  ul.nav li > a:hover {
color: #18286b !important;
  }

  .gc-header #header-navigation.new-design .block-menu .navbar-collapse ul.nav.navbar-nav > li.active,
  .gc-header #header-navigation.new-design .block-menu .navbar-collapse ul.nav.navbar-nav > li.active:hover > a{
background-color: #18286b !important;
  }

  .gc-header #header-navigation.new-design .block-menu .navbar-collapse ul.nav.navbar-nav > li.active {
color: #18286b;
  }

  .gc-header #header-navigation.new-design .block-menu .navbar-collapse ul.nav.navbar-nav .dropdown li.active > a {
color: #18286b !important;
  }

  .hcp-header-bar.new-design .mobile .block-accordion .accordion-items .panel-group .panel .panel-collapse {
background-color: #cbdf31 !important;
  }

  .hcp-header-bar.new-design .mobile .block-accordion .accordion-items .panel-group .panel .panel-heading .panel-title a {
background-color: #cbdf31 !important;
  }

  .hcp-header-bar.new-design .mobile .block-accordion .accordion-items .panel-group .panel .panel-heading .panel-title a.collapsed {
background-color: #18286b !important;
  }


  .primary-brand-color-bg {
background-color: #18286b;
  }
  .primary-brand-color-bg-hover:hover {
background-color: rgba(24,40,107,0.75);
  }
  .touch .primary-brand-color-bg-hover:hover {
background-color:  #18286b;
  }

  @media screen and (min-width: 1024px) {
.primary-brand-color-bg-hover-15:hover {

 background-color: rgba(24,40,107,0.15)!important;
}
  }
  .primary-brand-color-bg-hover-15-all:hover {

 background-color: rgba(24,40,107,0.15)!important;
  }
  .primary-brand-color-bg-transparent {
background-color: rgba(24,40,107,0.2);
  }
  .primary-brand-color-bg-transparent-tout {
background-color: rgba(24,40,107,0.2);
background-image:none !important;
  }
  .primary-brand-color .st0 {
fill:  #18286b;
  }

  .primary-brand-color svg {
fill:  #18286b;
  }
  .primary-brand-color-border {
border-color:  #18286b;
  }
  .primary-brand-color-border-rounded {
border:2px solid #18286b;
  }
  ol.primary-brand-color li:before {
color:  #18286b !important;
  }
  .ffb-component-form-field-checkbox:checked ~ label:before {
background-color: #18286b;
  }
  .gateway-home .gc-content .conditions > li a.feature-cta div {
background-color: #18286b;
  }
  .gateway-home .gc-content .conditions > li a.feature-cta:hover div {
background-color: rgba(24,40,107,0.85);
  }

  .product-printable-inventory-checkbox:checked ~ label {
background-color: #18286b!important;
  }
  #ffb-component-form #ffb-form-submit {
background-color:  #18286b;
  }
  #ffb-component-form #ffb-form-submit-continue {
background-color:  #18286b;
  }
  #ffb-form-submit-back {
border-color:#18286b;
color:#18286b;
  }
  #ffb-form-submit-back:hover {
background-color: #18286b;
color:white;
opacity:0.7;
  }
  .ffb-component-form-field-radiobutton:checked + label:before {
background-color: #18286b;
  }
  .product-hero-block {
background-color: #18286b;
  }
  .seemoreBlocksContainerBlock a {
color: #18286b;
  }
  .block-rich-text a {
color: #18286b;
  }
  .indication-menu-block a {

color:#18286b;
  }
  .products-detailed-content-block a {
color: #18286b;
  }
  .block-accordion-richtext-item panel-title a {
color: #18286b;
  }
  .product-expandable-callout-block .colapsed-header {
background-color: #18286b;
  }
  .product-expandable-callout-heading .panel-title {
color: #18286b;
  }
  .product-expandable-callout-block .inner.panel-default {
border:2px solid #18286b;
  }
  .product-expandable-callout-heading:hover {
background-color: #18286b;
  }
  .product-in-page-toggle-tab-item:hover {
background-color: #18286b;
  }
  .product-in-page-toggle-tab-item.active {
background-color: #18286b!important;
  }
  .product-in-page-toggle-tab-item {
border:1px solid #18286b;
  }
  .product-in-page-toggle-tabs {
border:2px solid #18286b;
  }
  .product-in-page-toggle-tab-item > a {
color: #18286b !important;
  }

  .block-accordion .accordion-items .panel-group .panel .panel-heading .panel-title a {
color: #18286b !important;
  }

  .ffb-component-rich-content-block a {
color: #18286b !important;
  }

  .ffb-component .btn-user-story {
background-color: #18286b !important;
  }
  .ffb-component .btn-user-story:hover {
background-color: rgba(24,40,107,0.8) !important;
  }

  .components .cobrand-cta h1,
  .components-c .componentb1 .cobrand-cta h1  {
color: #18286b !important;
  }

  .components .cobrand-cta .cta-label  {
border-color: #18286b !important;
color: #18286b !important;
  }

  .components .cobrand-cta .cta-label:hover {
background-color: #18286b;
color: #fff !important;
  }

  .components-c .componentb1 .cobrand-cta .cta-label  {
border-color: #18286b !important;
color: #18286b !important;
  }
  .components-c .componentb1 .cobrand-cta .cta-label:hover {
background-color: #18286b;
color: #fff !important;
  }

  .brand-landing-callouts-block.gray .headline,
  .brand-landing-callouts-block.gray .headline a {
color: #18286b !important;
  }

  .brand-landing-callouts-block.gray a.cta-button {
color: #18286b !important;
border-color: #18286b !important;
  }

  .brand-landing-callouts-block.gray a.cta-button:hover {
color: white !important;
border-color: #18286b !important;
background-color: #18286b !important;
opacity: 0.75;
  }

  .google-map-locator .centerfinder-filter .radio-container .radio:checked + .label-radio:before {
background-color: #18286b !important;
  }

  .block-franchise .btn-collapse {
background-color: #18286b !important;
  }

  @media screen and (min-width: 769px) {
.block-franchise .franchise a.active {
 background-color: #18286b !important;
}
  }
  @media screen and (max-width: 768px) {
.block-franchise .franchise {
 background-color: #18286b !important;
}
  }
</style>

 <style>
  .secondary-brand-color {
color: #cbdf31;
  }
  .secondary-brand-color a {
color: #cbdf31;
  }
  .secondary-brand-color a:hover {
color: #cbdf31;
opacity: 0.75;
  }
  .secondary-brand-color-border-rounded {
border:2px solid #cbdf31;
  }
  
  .secondary-brand-color .active {
-webkit-box-shadow:0px -4px 0px  #cbdf31 inset;
-moz-box-shadow:0px -4px 0px  #cbdf31 inset;
box-shadow:0px -4px 0px  #cbdf31 inset;
  }
  
  .secondary-brand-color-bg {
background-color: #cbdf31;
  }
  ol.secondary-brand-color li:before {
color:  #cbdf31 !important;
  }
  
 </style>


  <script>
			window.dataLayerOnco = window.dataLayerOnco || [];

			var preDataLayerOnco = {"environment":"STAGE","department":undefined,"indication":undefined,"brand":"jadenu","type":undefined,"sectionLevel1":"patient-support","sectionLevel2":"financial-resources","sectionLevel3":undefined,"status":undefined,"name":"jadenu : patient-support : financial-resources"};
			preDataLayerOnco.department = 'oncology';
			preDataLayerOnco.type = 'patient';
preDataLayerOnco.status = 200;
preDataLayerOnco.name = "patient : products : " + preDataLayerOnco.name;
			dataLayerOnco.push({
				'page':preDataLayerOnco
			});
  </script>
  <!-- Google Tag Manager -->
  <script>
(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
		new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
		j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
		'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
		})(window,document,'script','dataLayerOnco','GTM-NR5GSRT');</script>
  <!-- End Google Tag Manager -->

 <script>



			var displayGlobalPPDisclaimer = false;
 </script>

</head>
<body class="detailed-page">

 

  <!-- Google Tag Manager -->
  <noscript>
<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NR5GSRT" height="0" width="0" style="display:none;visibility:hidden"></iframe>
  </noscript>
  <!-- End Google Tag Manager -->

 <div class="container-fluid ">
  
 <div class="row gc-header">
  

<div class="container-fluid hcp-header-bar new-design" >


<div class="container " >
<div id="" class="block-rich-text  col-lg-2 col-md-2 col-sm-4 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">
  <p>For US residents only.</p>
 </div>
</div>
<div class="desktop col-lg-10 col-md-10 hidden-sm hidden-xs col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 " >
 



<div id="link-list-item-block-408890" class="link-list-item-block  ">
 <div class="inner">
  <div class="link-list-item-content">
<h2></h2>
 <a class="link-list-item-link primary-brand-color" href="https://www.hcp.novartis.com/products/jadenu/chronic-iron-overload/" target="_blank" data-target="none" data-hvce="" data-hvce-description="">
  <figure class="primary-brand-color">
 <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
viewBox="0 0 37.3 30" style="enable-background:new 0 0 37.3 30;" xml:space="preserve">
<style type="text/css">
 .st0 {
  fill: #FFFFFF;
 }
</style>
<path class="st0" d="M25.4,16.2v3.9H9V9.6h10.4V8.1H8.2c-0.4,0-0.7,0.3-0.7,0.8v12c0,0.4,0.3,0.8,0.7,0.8h18c0.4,0,0.8-0.3,0.8-0.8
	v-4.7H25.4z" />
<g>
 <path class="st0" d="M26.6,8.5c0.3,0.3,0.3,0.8,0,1.1l-5.2,5.2c-0.3,0.3-0.8,0.3-1.1,0c-0.3-0.3-0.3-0.8,0-1.1l5.2-5.2
		C25.8,8.2,26.3,8.2,26.6,8.5z" />
 <path class="st0" d="M26.6,8.5c0.1,0.1,0.2,0.3,0.2,0.5l0.1,2.9c0,0.4-0.3,0.8-0.7,0.8c-0.4,0-0.8-0.3-0.8-0.7l-0.1-2.2l-2.3-0.1
		c-0.4,0-0.7-0.4-0.7-0.8c0-0.4,0.4-0.7,0.8-0.7l3,0.1C26.3,8.2,26.5,8.3,26.6,8.5z" />
</g>
</svg>
</figure>
  Visit Health Care Professional Site
 </a>
  </div>
 </div>
</div>



<div id="link-list-item-block-408891" class="link-list-item-block  ">
 <div class="inner">
  <div class="link-list-item-content">
<h2></h2>
 <a class="link-list-item-link primary-brand-color" href="https://www.pharma.us.novartis.com/product/pi/pdf/jadenu.pdf" target="_blank" data-target="none" data-hvce="" data-hvce-description="">
<figure class="primary-brand-color">
 <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
viewBox="0 0 58 60.2" style="enable-background:new 0 0 58 60.2;" xml:space="preserve">
 <path d="M15.8,27.2H41c0.9,0,1.6-0.7,1.6-1.6v-8.8c0-0.9-0.7-1.6-1.6-1.6c-0.9,0-1.6,0.7-1.6,1.6v7.1h-22v-7.1
	c0-0.9-0.7-1.6-1.6-1.6s-1.6,0.7-1.6,1.6v8.8C14.1,26.5,14.9,27.2,15.8,27.2z M27.2,19L27.2,19c0.1,0.1,0.2,0.1,0.2,0.2l0,0
	c0.1,0,0.2,0.1,0.2,0.1l0,0c0.1,0,0.2,0.1,0.3,0.1l0,0c0.1,0,0.2,0,0.3,0c0.1,0,0.2,0,0.3,0l0,0c0.1,0,0.2,0,0.3-0.1l0,0
	c0.1,0,0.2-0.1,0.2-0.1l0,0c0.1,0,0.1-0.1,0.2-0.2l0,0l4.8-4.4c0.7-0.6,0.7-1.7,0.1-2.3c-0.6-0.7-1.7-0.7-2.3-0.1l-2,1.9V1.6
	c0-0.9-0.7-1.6-1.6-1.6s-1.6,0.7-1.6,1.6v12.5l-2-1.8c-0.7-0.6-1.7-0.6-2.3,0.1c-0.6,0.7-0.6,1.7,0.1,2.3L27.2,19z M16.6,38.3h-6.2
	v14.2h2.5v-5.4h3.8c4,0,4.8-2.6,4.8-4.3C21.4,40.9,20.6,38.3,16.6,38.3z M16.4,45h-3.6v-4.7h3.7c1.3,0,2.4,0.5,2.4,2.3
	C18.9,44.4,17.6,45,16.4,45z M47.7,40.4v-2.1h-9.8v14.2h2.5v-6.3h6.4v-2h-6.4v-3.7h7.3V40.4z M29.4,38.3h-5.9v14.2h5.9
	c4.4,0,6.2-3.2,6.2-7.1S33.8,38.3,29.4,38.3z M28.5,50.4H26V40.3h2.4c3.9,0,4.7,2.2,4.7,5.1C33.2,48.2,32.4,50.4,28.5,50.4z" />
</svg>
</figure>
 Prescribing Information
 </a>
  </div>
 </div>
</div>
</div>
<div class="mobile hidden-lg hidden-md col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 " >
 



<div id="link-list-item-block-408895" class="link-list-item-block primary-brand-color-bg col-lg-7 col-md-7 col-sm-7 col-xs-7 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">
  <div class="link-list-item-content">
<h2></h2>
 <a class="link-list-item-link primary-brand-color" href="https://www.pharma.us.novartis.com/product/pi/pdf/jadenu.pdf" target="_blank" data-target="none" data-hvce="" data-hvce-description="">
<figure class="primary-brand-color">
 <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
viewBox="0 0 58 60.2" style="enable-background:new 0 0 58 60.2;" xml:space="preserve">
 <path d="M15.8,27.2H41c0.9,0,1.6-0.7,1.6-1.6v-8.8c0-0.9-0.7-1.6-1.6-1.6c-0.9,0-1.6,0.7-1.6,1.6v7.1h-22v-7.1
	c0-0.9-0.7-1.6-1.6-1.6s-1.6,0.7-1.6,1.6v8.8C14.1,26.5,14.9,27.2,15.8,27.2z M27.2,19L27.2,19c0.1,0.1,0.2,0.1,0.2,0.2l0,0
	c0.1,0,0.2,0.1,0.2,0.1l0,0c0.1,0,0.2,0.1,0.3,0.1l0,0c0.1,0,0.2,0,0.3,0c0.1,0,0.2,0,0.3,0l0,0c0.1,0,0.2,0,0.3-0.1l0,0
	c0.1,0,0.2-0.1,0.2-0.1l0,0c0.1,0,0.1-0.1,0.2-0.2l0,0l4.8-4.4c0.7-0.6,0.7-1.7,0.1-2.3c-0.6-0.7-1.7-0.7-2.3-0.1l-2,1.9V1.6
	c0-0.9-0.7-1.6-1.6-1.6s-1.6,0.7-1.6,1.6v12.5l-2-1.8c-0.7-0.6-1.7-0.6-2.3,0.1c-0.6,0.7-0.6,1.7,0.1,2.3L27.2,19z M16.6,38.3h-6.2
	v14.2h2.5v-5.4h3.8c4,0,4.8-2.6,4.8-4.3C21.4,40.9,20.6,38.3,16.6,38.3z M16.4,45h-3.6v-4.7h3.7c1.3,0,2.4,0.5,2.4,2.3
	C18.9,44.4,17.6,45,16.4,45z M47.7,40.4v-2.1h-9.8v14.2h2.5v-6.3h6.4v-2h-6.4v-3.7h7.3V40.4z M29.4,38.3h-5.9v14.2h5.9
	c4.4,0,6.2-3.2,6.2-7.1S33.8,38.3,29.4,38.3z M28.5,50.4H26V40.3h2.4c3.9,0,4.7,2.2,4.7,5.1C33.2,48.2,32.4,50.4,28.5,50.4z" />
</svg>
</figure>
 Prescribing Information
 </a>
  </div>
 </div>
</div>



<div id="block-accordion-408896" class="block-accordion clearfix primary-brand-color-bg " data-hvce="" data-hvce-description="">
 

 <div class="inner">

  <div class="accordion-items clearfix">
<div id="block-accordion-408896-group" class="panel-group" role="tablist" aria-multiselectable="true" >
 

<div class="panel panel-default block-accordion-content-item">
 <div class="panel-heading" role="tab" id="heading-408898">
  <h4 class="panel-title">
<a role="button" data-toggle="collapse" data-parent="#block-accordion-408896-group" href="index.html#panel-408898" aria-expanded="false" aria-controls="panel-408898" class="collapsed" >
 HCP Websites
</a>
  </h4>
 </div>
 <div id="panel-408898" class="panel-collapse collapse " role="tabpanel" aria-labelledby="heading-408898">
  <div class="panel-body" >




<div id="link-list-item-block-408900" class="link-list-item-block  ">
 <div class="inner">
  <div class="link-list-item-content">
<h2></h2>
 <a class="link-list-item-link primary-brand-color" href="https://www.hcp.novartis.com/products/jadenu/chronic-iron-overload" target="_blank" data-target="none" data-hvce="" data-hvce-description="">
  <figure class="primary-brand-color">
 <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
viewBox="0 0 37.3 30" style="enable-background:new 0 0 37.3 30;" xml:space="preserve">
<style type="text/css">
 .st0 {
  fill: #FFFFFF;
 }
</style>
<path class="st0" d="M25.4,16.2v3.9H9V9.6h10.4V8.1H8.2c-0.4,0-0.7,0.3-0.7,0.8v12c0,0.4,0.3,0.8,0.7,0.8h18c0.4,0,0.8-0.3,0.8-0.8
	v-4.7H25.4z" />
<g>
 <path class="st0" d="M26.6,8.5c0.3,0.3,0.3,0.8,0,1.1l-5.2,5.2c-0.3,0.3-0.8,0.3-1.1,0c-0.3-0.3-0.3-0.8,0-1.1l5.2-5.2
		C25.8,8.2,26.3,8.2,26.6,8.5z" />
 <path class="st0" d="M26.6,8.5c0.1,0.1,0.2,0.3,0.2,0.5l0.1,2.9c0,0.4-0.3,0.8-0.7,0.8c-0.4,0-0.8-0.3-0.8-0.7l-0.1-2.2l-2.3-0.1
		c-0.4,0-0.7-0.4-0.7-0.8c0-0.4,0.4-0.7,0.8-0.7l3,0.1C26.3,8.2,26.5,8.3,26.6,8.5z" />
</g>
</svg>
</figure>
  Visit Health Care Professional Site
 </a>
  </div>
 </div>
</div>
  </div>
 </div>
</div>
</div>
  </div>
 </div>
</div>
</div></div></div>

<div class="container new-design" id="header-navigation">
<div class="logo  col-lg-3 col-md-3 col-sm-3 col-xs-4 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <a href="../../index.html" target="" class="text-normal">
  <img class="img-responsive" src="../../globalassets/products/jadenu/images/logo-jadenu2.jpg" alt=" JADENU(R) (deferasirox) tablets can treat people with chronic iron overload (IO)" />
 </a>
</div>
<div class="block-menu  col-lg-9 col-md-9 col-sm-9 col-xs-8 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">

<nav class="navbar navbar-default">
 <div class="container-fluid">
  <div class="navbar-header">
<button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false">
 <span class="sr-only">Toggle navigation</span>
 <span class="icon-bar"></span>
 <span class="icon-bar"></span>
 <span class="icon-bar"></span>
</button>
<div class="navbar-logo">
 
</div>
  </div>
  <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">

  <ul class="nav navbar-nav "><li><a href="../../index.html" class="">Home</a><li class="dropdown "><a class="dropdown-toggle" data-toggle="dropdown" href="index.html">About Disease<span class="caret"></span></a><ul class="dropdown-menu "><li><a href="../../about-the-disease/understanding-the-disease/index.html" class="">Understanding the Disease</a></li><li><a href="../../about-the-disease/signs-symptoms/index.html" class="">Signs & Symptoms</a></li><li><a href="../../about-the-disease/diagnosis/index.html" class="">Diagnosis</a></li></ul></li><li class="dropdown "><a class="dropdown-toggle" data-toggle="dropdown" href="index.html">About Treatment<span class="caret"></span></a><ul class="dropdown-menu "><li><a href="../../about-treatment/understanding-treatment/index.html" class="">Understanding Treatment</a></li><li><a href="../../about-treatment/how-treatment-may-help/index.html" class="">How Treatment May Help</a></li><li><a href="../../about-treatment/how-to-take/index.html" class="">How to Take Treatment</a></li><li><a href="../../about-treatment/monitoring/index.html" class="">Monitoring Treatment</a></li></ul></li><li class="dropdown "><a class="dropdown-toggle" data-toggle="dropdown" href="index.html">Side Effects<span class="caret"></span></a><ul class="dropdown-menu "><li><a href="../../side-effects/understanding-side-effects/index.html" class="">Understanding Side Effects</a></li></ul></li><li class="dropdown  active "><a class="dropdown-toggle" data-toggle="dropdown" href="index.html">Patient Support<span class="caret"></span></a><ul class="dropdown-menu "><li class=" active "><a href="index.html" class="">Financial Resources</a></li><li><a href="../frequently-asked-questions/index.html" class="">Frequently Asked Questions</a></li><li><a href="../how-to-get-treatment/index.html" class="">How to Get Treatment</a></li><li><a href="../download-helpful-materials/index.html" class="">Resources & Support</a></li></ul></li></ul>

</div><!-- /.navbar-collapse -->
</div><!-- /.container-fluid -->
</nav>
<style>
 .dropdown-submenu {
  position: relative;
 }

  .dropdown-submenu > .dropdown-menu {
top: 0;
left: 100%;
margin-top: -6px;
margin-left: -1px;
-webkit-border-radius: 0 6px 6px 6px;
-moz-border-radius: 0 6px 6px 6px;
border-radius: 0 6px 6px 6px;
  }

  .dropdown-submenu:hover > .dropdown-menu {
display: block;
  }

  .dropdown-submenu > a:after {
display: block;
content: " ";
float: right;
width: 0;
height: 0;
border-color: transparent;
border-style: solid;
border-width: 5px 0 5px 5px;
border-left-color: #cccccc;
margin-top: 5px;
margin-right: -10px;
  }

  .dropdown-submenu:hover > a:after {
border-left-color: #ffffff;
  }

  .dropdown-submenu.pull-left {
float: none;
  }

.dropdown-submenu.pull-left > .dropdown-menu {
 left: -100%;
 margin-left: 10px;
 -webkit-border-radius: 6px 0 6px 6px;
 -moz-border-radius: 6px 0 6px 6px;
 border-radius: 6px 0 6px 6px;
}
</style>
 </div>
</div></div>
 </div>


 <div class="row gc-subNav">
  

<div class="container-fluid primary-brand-color-bg" >


<div class="container " >
<div id="" class="block-rich-text detail-page-title-block col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">
  <h1>Financial Resources</h1>
<h2>JADENU<sup>®</sup> Sprinkle (deferasirox) granules and JADENU<sup>®</sup> (deferasirox) tablets</h2>
 </div>
</div></div></div>
 </div>
  <main>
 <div class="row gc-content">
  <div class="container ">
<div class="row">
 <aside class="gc-content-right-column col-md-3 col-md-push-9">
  



<div id="SeemoreBlocksContainerBlock-5255" class="seemoreBlocksContainerBlock seemoreBlocksContainerBlockMobile  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <button class="btn btn-primary collapsed" type="button" data-toggle="collapse" data-target="#collapseSeeMoreContainer" aria-expanded="false" aria-controls="collapseSeeMoreContainer">
  <span class="text">Important Safety Information, including Boxed WARNING:</span>
  <span class="isi-icon-mobile"><img src="../../modules/DigiOne.Products/Client/Static/Images/Icons/isi-plus-icon.png" alt="" /></span>
 </button>
 <div class="collapse" id="collapseSeeMoreContainer">
<span class="title"> Important Safety Information, including Boxed WARNING: </span>
<div class="content"> <p><strong>What is the most important safety information to know about JADENU?</strong></p>
<p>&nbsp;</p>
<p><strong>JADENU contains deferasirox, the same active ingredient in EXJADE<sup>®</sup>&nbsp;(deferasirox) tablets for oral suspension. Deferasirox may cause serious kidney problems, liver problems, and bleeding in the stomach or intestines. In some cases, these problems were fatal. Kidney problems occurred particularly in patients with multiple medical conditions and those who were very ill because of their disease. Bleeding in the stomach or intestines occurred more often in elderly patients. Liver problems were more likely to happen in patients older than 55 years.&nbsp;</strong></p>
<p>&nbsp;</p>
<p><strong>Your doctor should check your kidney function with blood tests and urinalyses:</strong></p>
<ul>
<li><strong>Before taking JADENU</strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>If you already have a history of kidney problems or are at risk for kidney problems, your doctor should check your&nbsp;kidneys:</strong></p>
<ul>
<li><strong>Every week for the first&nbsp;month</strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>Your doctor should check your liver function with blood tests:</strong></p>
<ul>
<li><strong>Before taking JADENU</strong></li>
<li><strong>Every other week for the first month after starting&nbsp;JADENU</strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>You should not take JADENU if you&nbsp;have:</strong></p>
<ul>
<li>Certain kinds of kidney problems</li>
<li>Preexisting severe liver problems</li>
<li>High-risk myelodysplastic syndromes (MDS)</li>
<li>Advanced cancer</li>
<li>Low blood counts (low platelets)</li>
<li>An allergy to JADENU or any ingredient of&nbsp;JADENU</li>
</ul>
<p><strong>Additional Important Safety Information</strong></p>
<p>&nbsp;</p>
<p><strong>Kidneys</strong></p>
<ul>
<li>If you have a preexisting kidney condition, are elderly, have multiple medical conditions, or are taking medicine that affects your kidneys, you are at increased risk of complications. Your doctor will do blood tests (serum creatinine and/or creatinine clearance, estimated glomerular filtration rate (eGFR), and serum electrolytes) every week for the first month you are taking JADENU or if your dose has changed, and then every month after that. Your doctor may adjust your dose based on the results of these&nbsp;tests</li>
<li>Your doctor will also collect urine samples&nbsp;monthly</li>
<li>Some patients developed severe kidney problems while taking deferasirox, in some cases fatal, and in some cases requiring dialysis. Most of the fatalities occurred in patients who were very ill because of their&nbsp;disease</li>
</ul>
<p>In younger patients, stop taking JADENU during serious illnesses that can cause dehydration such as vomiting, diarrhea, or prolonged decreased oral intake.</p>
<p>&nbsp;</p>
<p><strong>Liver</strong></p>
<ul>
<li>If you have a preexisting severe liver problem, you should not use&nbsp;JADENU</li>
<li>If you have mild or moderate liver problems, your doctor will do blood tests (serum transaminases and bilirubin) before starting treatment, every 2 weeks during the first month of treatment, and then monthly. Your doctor may adjust your dose based on the results of these&nbsp;tests</li>
<li>Some patients developed severe liver problems, in some cases fatal, while taking deferasirox. Many of these patients were older than 55&nbsp;years of age and/or had multiple medical conditions already affecting their&nbsp;liver</li>
</ul>
<p><strong>Bleeding in the Stomach or Intestines</strong></p>
<ul>
<li>Some patients developed stomach irritation or bleeds while taking deferasirox. In some cases, stomach bleeds were fatal, usually in patients who were elderly and had preexisting blood cancers and/or low blood counts (low&nbsp;platelets)</li>
<li>Talk to your doctor if you are taking other drugs that can also irritate your stomach or cause a stomach bleed (eg,&nbsp;pain&nbsp;relievers/anti-inflammatory drugs, corticosteroids, oral bisphosphonates, or blood&nbsp;thinners)</li>
</ul>
<p><strong>Blood Disorders</strong></p>
<ul>
<li>Some patients developed severe blood disorders, in some cases fatal, while on deferasirox therapy.&nbsp;Having a preexisting blood disorder may increase the risk</li>
<li>Your doctor will do a blood test to check your blood&nbsp;counts</li>
</ul>
<p><strong>Increased Risks With Different Ages</strong></p>
<ul>
<li><em>Elderly Patients</em>: Since deferasirox has been on the market, there have been reports of serious reactions, sometimes leading to death. These serious reactions and deaths have happened most often when deferasirox was taken by elderly&nbsp;patients</li>
<li><em>Pediatric Patients</em>: Serious and fatal events have occurred in pediatric patients. These were associated with dehydration or when dosing is continued as the iron burden is in the range of normal</li>
</ul>
<p><strong>Allergic Reactions</strong></p>
<ul>
<li>Serious allergic reactions (which include swelling of the throat) have been reported in patients taking deferasirox, usually within the first month of&nbsp;treatment</li>
<li>If you develop swelling of the throat, a severe rash, hearing problems, or vision disturbances, stop taking JADENU and contact your doctor&nbsp;immediately</li>
</ul>
<p><strong>Severe Skin Reactions</strong></p>
<ul>
<li>Severe skin disorders that result in a very serious rash, called Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme have been reported during treatment with deferasirox. Other skin reactions including DRESS (drug reaction with eosinophilia and systemic symptoms) can also occur. If you develop a severe rash, stop taking JADENU and contact your doctor&nbsp;immediately</li>
<li>Mild to moderate skin rashes may occur during treatment with deferasirox. Let your doctor know if the rash doesn’t go away on its own or gets worse. Your doctor may need to change your dose of&nbsp;JADENU</li>
</ul>
<p><strong>Hearing and Vision Changes</strong></p>
<ul>
<li>Changes to hearing and vision have been reported in patients taking deferasirox. If you notice changes in your hearing or eyesight, contact your doctor&nbsp;immediately</li>
<li>You may also receive a hearing or vision test prior to receiving JADENU, and yearly thereafter. Your doctor may change your dose based on the results of these&nbsp;tests</li>
</ul>
<p><strong>Common Side Effects</strong></p>
<ul>
<li>The most commonly reported side effects related to deferasirox in clinical trials were mainly nausea, vomiting, diarrhea, stomach pain, increases in kidney laboratory values, and skin&nbsp;rash</li>
<li>Let your doctor know if you are experiencing any side effects. Your doctor may need to change your&nbsp;dose</li>
<li>If you experience diarrhea or vomiting, you must continue to drink&nbsp;fluids</li>
<li>You are encouraged to report negative side effects of prescription drugs to the FDA. Visit<strong>&nbsp;<a href="http://www.fda.gov/medwatch" target="_blank" rel="nofollow" data-target="#interstitialPopUp">www.fda.gov/medwatch</a></strong>,&nbsp;or call&nbsp;<a href="tel:1-800-332-1088">1-800-FDA-1088</a></li>
</ul>
<p><strong>Taking Other Medicines With&nbsp;JADENU</strong></p>
<ul>
<li>If you are taking other medicines, such as birth control pills, diabetes drugs, seizure drugs, cholesterol-lowering drugs, or medicine for serious illnesses, talk to your doctor. JADENU may affect how these drugs&nbsp;work</li>
</ul>
<p>Talk to your doctor to determine if prescription JADENU therapy is right for&nbsp;you.</p>
<p>&nbsp;</p>
<p><strong><a title="Please see full Prescribing Information, including Boxed WARNING, for JADENU (deferasirox)." href="https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/jadenu.pdf" target="_blank">Please see full Prescribing Information, including Boxed WARNING, for JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle (deferasirox) granules.</a></strong></p>
<p><b>&nbsp;</b></p> </div>
<span class="title"> INDICATION </span>
<div class="content"> <p><strong>Treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron&nbsp;Overload)</strong></p>
<p>JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle&nbsp;(deferasirox) granules are indicated for the treatment of chronically elevated levels of iron in the blood caused by repeated blood transfusions (transfusional hemosiderosis) in patients 2&nbsp;years of age and&nbsp;older.</p>
<p>&nbsp;</p>
<p><strong>Limitation on the Use of JADENU</strong></p>
<p>It is not known if JADENU is safe or effective when taken with another therapy that lowers iron levels in the&nbsp;blood.</p> </div>
  <div class="collapseSeeMoreContainer-close" data-toggle="collapse" data-target="#collapseSeeMoreContainer" aria-expanded="false" aria-controls="collapseSeeMoreContainer">< Back To Site</div>
 </div>
</div>




 <div id="QuickLinkBlock-1154" class="quickLinkBlock anchorLinkType primary-brand-color col-lg-12 col-md-12 col-sm-12 col-xs-6 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 " >
  <div class="inner">
<a href="http://www.pharma.us.novartis.com/product/pi/pdf/jadenu.pdf" target=_blank data-target="none" data-hvce="" data-hvce-description="">
 <figure>
  <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
 viewBox="0 0 58 60.2" style="enable-background:new 0 0 58 60.2;" xml:space="preserve">
  <path d="M15.8,27.2H41c0.9,0,1.6-0.7,1.6-1.6v-8.8c0-0.9-0.7-1.6-1.6-1.6c-0.9,0-1.6,0.7-1.6,1.6v7.1h-22v-7.1
	c0-0.9-0.7-1.6-1.6-1.6s-1.6,0.7-1.6,1.6v8.8C14.1,26.5,14.9,27.2,15.8,27.2z M27.2,19L27.2,19c0.1,0.1,0.2,0.1,0.2,0.2l0,0
	c0.1,0,0.2,0.1,0.2,0.1l0,0c0.1,0,0.2,0.1,0.3,0.1l0,0c0.1,0,0.2,0,0.3,0c0.1,0,0.2,0,0.3,0l0,0c0.1,0,0.2,0,0.3-0.1l0,0
	c0.1,0,0.2-0.1,0.2-0.1l0,0c0.1,0,0.1-0.1,0.2-0.2l0,0l4.8-4.4c0.7-0.6,0.7-1.7,0.1-2.3c-0.6-0.7-1.7-0.7-2.3-0.1l-2,1.9V1.6
	c0-0.9-0.7-1.6-1.6-1.6s-1.6,0.7-1.6,1.6v12.5l-2-1.8c-0.7-0.6-1.7-0.6-2.3,0.1c-0.6,0.7-0.6,1.7,0.1,2.3L27.2,19z M16.6,38.3h-6.2
	v14.2h2.5v-5.4h3.8c4,0,4.8-2.6,4.8-4.3C21.4,40.9,20.6,38.3,16.6,38.3z M16.4,45h-3.6v-4.7h3.7c1.3,0,2.4,0.5,2.4,2.3
	C18.9,44.4,17.6,45,16.4,45z M47.7,40.4v-2.1h-9.8v14.2h2.5v-6.3h6.4v-2h-6.4v-3.7h7.3V40.4z M29.4,38.3h-5.9v14.2h5.9
	c4.4,0,6.2-3.2,6.2-7.1S33.8,38.3,29.4,38.3z M28.5,50.4H26V40.3h2.4c3.9,0,4.7,2.2,4.7,5.1C33.2,48.2,32.4,50.4,28.5,50.4z" />
</svg>
 </figure>
  <div class="content primary-brand-color"> <p>Prescribing Information</p> </div> </a>
  </div>
 </div>









 <div id="QuickLinkBlock-409093" class="quickLinkBlock phoneNumberLinkType primary-brand-color col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
  <div class="inner">
<div class="desktop">
 <a href="tel:1-800-282-7630">
<figure>

 <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
viewBox="0 0 37.2 51" style="enable-background:new 0 0 37.2 51;" xml:space="preserve">
 <style type="text/css">

  .st0{fill:#3C5EA8;}
 </style>
 <circle class="st0" cx="18.8" cy="42.1" r="1.1" />
 <g>
<path class="st0" d="M29.6,46.4H7.9c-1.4,0-2.6-1.2-2.6-2.6V7.1c0-1.4,1.2-2.6,2.6-2.6h21.6c1.4,0,2.6,1.2,2.6,2.6v36.6
		 C32.2,45.2,31,46.4,29.6,46.4z M7.9,6.6c-0.3,0-0.6,0.3-0.6,0.6v36.6c0,0.3,0.3,0.6,0.6,0.6h21.6c0.3,0,0.6-0.3,0.6-0.6V7.1
		 c0-0.3-0.3-0.6-0.6-0.6H7.9z" />
 </g>
 <g>
  <path class="st0" d="M31.7,39.3H5.8V10.6h25.8V39.3z M6.8,38.3h23.8V11.6H6.8V38.3z" />
 </g>
 <path class="st0" d="M23.1,8.1c0,0.2-0.2,0.4-0.4,0.4h-8.1c-0.2,0-0.4-0.2-0.4-0.4l0,0c0-0.2,0.2-0.4,0.4-0.4h8.1
	 C22.9,7.7,23.1,7.9,23.1,8.1L23.1,8.1z" />
 </svg>
</figure>
  <div class="content primary-brand-color"> <p>Patient Support Line <span class="nobreak">1-888-282-7630</span>,<br /> Mon - Fri: 8 <span style="font-variant: small-caps;">am</span>–8 <span style="font-variant: small-caps;">pm</span> ET</p> </div>
 </a>
</div>

<div class="mobile">
 <a href="tel:1-800-282-7630">
<figure>

 <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
viewBox="0 0 37.2 51" style="enable-background:new 0 0 37.2 51;" xml:space="preserve">
 <style type="text/css">

  .st0{fill:#3C5EA8;}
 </style>
 <circle class="st0" cx="18.8" cy="42.1" r="1.1" />
 <g>
 <path class="st0" d="M29.6,46.4H7.9c-1.4,0-2.6-1.2-2.6-2.6V7.1c0-1.4,1.2-2.6,2.6-2.6h21.6c1.4,0,2.6,1.2,2.6,2.6v36.6
		 C32.2,45.2,31,46.4,29.6,46.4z M7.9,6.6c-0.3,0-0.6,0.3-0.6,0.6v36.6c0,0.3,0.3,0.6,0.6,0.6h21.6c0.3,0,0.6-0.3,0.6-0.6V7.1
		 c0-0.3-0.3-0.6-0.6-0.6H7.9z" />
 </g>
 <g>
 <path class="st0" d="M31.7,39.3H5.8V10.6h25.8V39.3z M6.8,38.3h23.8V11.6H6.8V38.3z" />
 </g>
 <path class="st0" d="M23.1,8.1c0,0.2-0.2,0.4-0.4,0.4h-8.1c-0.2,0-0.4-0.2-0.4-0.4l0,0c0-0.2,0.2-0.4,0.4-0.4h8.1
	 C22.9,7.7,23.1,7.9,23.1,8.1L23.1,8.1z" />
 </svg>
</figure>
<div class="content primary-brand-color"> <p>Patient Support Line <span class="nobreak">1-888-282-7630</span>,<br /> Mon - Fri: 8 <span style="font-variant: small-caps;">am</span>–8 <span style="font-variant: small-caps;">pm</span> ET</p> </div>  </a>
</div>
  </div>
 </div>









<div id="SeemoreBlocksContainerBlock-1131" class="seemoreBlocksContainerBlock  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">

 




<div id="SeemoreBlock-16250" class="seemoreBlock  ">
 <span class="title"> Important Safety Information, including Boxed WARNING: </span>

  <div class="content">

<p><strong>What is the most important safety information to know about JADENU?</strong></p><p>&nbsp;</p><p><strong>JADENU contains deferasirox, the same active ingredient in EXJADE<sup>®</sup>&nbsp;(deferasirox) tablets for oral suspension. Deferasirox<span class='ellipsis'>...</span></strong></p><ul><li><strong><a href="http://www.fda.gov/medwatch" target="_blank" rel="nofollow" data-target="#interstitialPopUp"></a></strong></li></ul>


 <a href="index.html#" class="CTALabel primary-brand-color" data-toggle="modal"> See More </a> 

  </div>
</div>





<div id="SeemoreBlock-16251" class="seemoreBlock  ">
 <span class="title"> INDICATION </span>

  <div class="content">

<p><strong>Treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron&nbsp;Overload)</strong></p><p>JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle&nbsp;(deferasirox) granules are indicated for the treatment of chronically elevated levels of iron in the blood caus<span class='ellipsis'>...</span></p>


 <a href="index.html#" class="CTALabel primary-brand-color" data-toggle="modal"> See More </a> 

  </div>
<button class="CTALabel primary-brand-color-bg primary-brand-color-bg-hover" data-toggle="modal">
 <span class="secondary-brand-color glyphicon glyphicon-menu-left arrow-dont-delete" aria-hidden="true"></span>
Read Full Important Safety Information and Approved Use</button>
</div>



 <div id="seeMoreModal-1131" class="seemoreModal modal fade">
  <div class="modal-dialog">
<div class="modal-content">
 <div class="modal-body">

  <div id="ISIModalScrollbar">
<div class="scrollbar"><div class="track"><div class="thumb"><div class="end"></div></div></div></div>
<div class="viewport">
 <div class="overview">
  <div class="seemoreBlockExpanded"><span class="title"> Important Safety Information, including Boxed WARNING:</span><div class="content"><p><strong>What is the most important safety information to know about JADENU?</strong></p>
<p>&nbsp;</p>
<p><strong>JADENU contains deferasirox, the same active ingredient in EXJADE<sup>®</sup>&nbsp;(deferasirox) tablets for oral suspension. Deferasirox may cause serious kidney problems, liver problems, and bleeding in the stomach or intestines. In some cases, these problems were fatal. Kidney problems occurred particularly in patients with multiple medical conditions and those who were very ill because of their disease. Bleeding in the stomach or intestines occurred more often in elderly patients. Liver problems were more likely to happen in patients older than 55 years.&nbsp;</strong></p>
<p>&nbsp;</p>
<p><strong>Your doctor should check your kidney function with blood tests and urinalyses:</strong></p>
<ul>
<li><strong>Before taking JADENU</strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>If you already have a history of kidney problems or are at risk for kidney problems, your doctor should check your&nbsp;kidneys:</strong></p>
<ul>
<li><strong>Every week for the first&nbsp;month</strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>Your doctor should check your liver function with blood tests:</strong></p>
<ul>
<li><strong>Before taking JADENU</strong></li>
<li><strong>Every other week for the first month after starting&nbsp;JADENU</strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>You should not take JADENU if you&nbsp;have:</strong></p>
<ul>
<li>Certain kinds of kidney problems</li>
<li>Preexisting severe liver problems</li>
<li>High-risk myelodysplastic syndromes (MDS)</li>
<li>Advanced cancer</li>
<li>Low blood counts (low platelets)</li>
<li>An allergy to JADENU or any ingredient of&nbsp;JADENU</li>
</ul>
<p><strong>Additional Important Safety Information</strong></p>
<p>&nbsp;</p>
<p><strong>Kidneys</strong></p>
<ul>
<li>If you have a preexisting kidney condition, are elderly, have multiple medical conditions, or are taking medicine that affects your kidneys, you are at increased risk of complications. Your doctor will do blood tests (serum creatinine and/or creatinine clearance, estimated glomerular filtration rate (eGFR), and serum electrolytes) every week for the first month you are taking JADENU or if your dose has changed, and then every month after that. Your doctor may adjust your dose based on the results of these&nbsp;tests</li>
<li>Your doctor will also collect urine samples&nbsp;monthly</li>
<li>Some patients developed severe kidney problems while taking deferasirox, in some cases fatal, and in some cases requiring dialysis. Most of the fatalities occurred in patients who were very ill because of their&nbsp;disease</li>
</ul>
<p>In younger patients, stop taking JADENU during serious illnesses that can cause dehydration such as vomiting, diarrhea, or prolonged decreased oral intake.</p>
<p>&nbsp;</p>
<p><strong>Liver</strong></p>
<ul>
<li>If you have a preexisting severe liver problem, you should not use&nbsp;JADENU</li>
<li>If you have mild or moderate liver problems, your doctor will do blood tests (serum transaminases and bilirubin) before starting treatment, every 2 weeks during the first month of treatment, and then monthly. Your doctor may adjust your dose based on the results of these&nbsp;tests</li>
<li>Some patients developed severe liver problems, in some cases fatal, while taking deferasirox. Many of these patients were older than 55&nbsp;years of age and/or had multiple medical conditions already affecting their&nbsp;liver</li>
</ul>
<p><strong>Bleeding in the Stomach or Intestines</strong></p>
<ul>
<li>Some patients developed stomach irritation or bleeds while taking deferasirox. In some cases, stomach bleeds were fatal, usually in patients who were elderly and had preexisting blood cancers and/or low blood counts (low&nbsp;platelets)</li>
<li>Talk to your doctor if you are taking other drugs that can also irritate your stomach or cause a stomach bleed (eg,&nbsp;pain&nbsp;relievers/anti-inflammatory drugs, corticosteroids, oral bisphosphonates, or blood&nbsp;thinners)</li>
</ul>
<p><strong>Blood Disorders</strong></p>
<ul>
<li>Some patients developed severe blood disorders, in some cases fatal, while on deferasirox therapy.&nbsp;Having a preexisting blood disorder may increase the risk</li>
<li>Your doctor will do a blood test to check your blood&nbsp;counts</li>
</ul>
<p><strong>Increased Risks With Different Ages</strong></p>
<ul>
<li><em>Elderly Patients</em>: Since deferasirox has been on the market, there have been reports of serious reactions, sometimes leading to death. These serious reactions and deaths have happened most often when deferasirox was taken by elderly&nbsp;patients</li>
<li><em>Pediatric Patients</em>: Serious and fatal events have occurred in pediatric patients. These were associated with dehydration or when dosing is continued as the iron burden is in the range of normal</li>
</ul>
<p><strong>Allergic Reactions</strong></p>
<ul>
<li>Serious allergic reactions (which include swelling of the throat) have been reported in patients taking deferasirox, usually within the first month of&nbsp;treatment</li>
<li>If you develop swelling of the throat, a severe rash, hearing problems, or vision disturbances, stop taking JADENU and contact your doctor&nbsp;immediately</li>
</ul>
<p><strong>Severe Skin Reactions</strong></p>
<ul>
<li>Severe skin disorders that result in a very serious rash, called Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme have been reported during treatment with deferasirox. Other skin reactions including DRESS (drug reaction with eosinophilia and systemic symptoms) can also occur. If you develop a severe rash, stop taking JADENU and contact your doctor&nbsp;immediately</li>
<li>Mild to moderate skin rashes may occur during treatment with deferasirox. Let your doctor know if the rash doesn’t go away on its own or gets worse. Your doctor may need to change your dose of&nbsp;JADENU</li>
</ul>
<p><strong>Hearing and Vision Changes</strong></p>
<ul>
<li>Changes to hearing and vision have been reported in patients taking deferasirox. If you notice changes in your hearing or eyesight, contact your doctor&nbsp;immediately</li>
<li>You may also receive a hearing or vision test prior to receiving JADENU, and yearly thereafter. Your doctor may change your dose based on the results of these&nbsp;tests</li>
</ul>
<p><strong>Common Side Effects</strong></p>
<ul>
<li>The most commonly reported side effects related to deferasirox in clinical trials were mainly nausea, vomiting, diarrhea, stomach pain, increases in kidney laboratory values, and skin&nbsp;rash</li>
<li>Let your doctor know if you are experiencing any side effects. Your doctor may need to change your&nbsp;dose</li>
<li>If you experience diarrhea or vomiting, you must continue to drink&nbsp;fluids</li>
<li>You are encouraged to report negative side effects of prescription drugs to the FDA. Visit<strong>&nbsp;<a href="http://www.fda.gov/medwatch" target="_blank" rel="nofollow" data-target="#interstitialPopUp">www.fda.gov/medwatch</a></strong>,&nbsp;or call&nbsp;<a href="tel:1-800-332-1088">1-800-FDA-1088</a></li>
</ul>
<p><strong>Taking Other Medicines With&nbsp;JADENU</strong></p>
<ul>
<li>If you are taking other medicines, such as birth control pills, diabetes drugs, seizure drugs, cholesterol-lowering drugs, or medicine for serious illnesses, talk to your doctor. JADENU may affect how these drugs&nbsp;work</li>
</ul>
<p>Talk to your doctor to determine if prescription JADENU therapy is right for&nbsp;you.</p>
<p>&nbsp;</p>
<p><strong><a title="Please see full Prescribing Information, including Boxed WARNING, for JADENU (deferasirox)." href="https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/jadenu.pdf" target="_blank">Please see full Prescribing Information, including Boxed WARNING, for JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle (deferasirox) granules.</a></strong></p>
<p><b>&nbsp;</b></p></div></div><div class="seemoreBlockExpanded"><span class="title"> INDICATION</span><div class="content"><p><strong>Treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron&nbsp;Overload)</strong></p>
<p>JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle&nbsp;(deferasirox) granules are indicated for the treatment of chronically elevated levels of iron in the blood caused by repeated blood transfusions (transfusional hemosiderosis) in patients 2&nbsp;years of age and&nbsp;older.</p>
<p>&nbsp;</p>
<p><strong>Limitation on the Use of JADENU</strong></p>
<p>It is not known if JADENU is safe or effective when taken with another therapy that lowers iron levels in the&nbsp;blood.</p></div></div>
 </div>
</div>
  </div>

  
  <div class="bottomBar primary-brand-color-bg">
<span class="secondary-brand-color glyphicon glyphicon-menu-left" aria-hidden="true"></span>

<span class="text">Back To Site</span>
  </div>


 </div>
</div>
  </div>
 </div>
</div>

 </aside>
 <div class="gc-content-left-column col-md-9 col-md-pull-3">










 <div id="editorialCopayBlock-27387" class="editorialCopayBlock coPay  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 " data-hvce="" data-hvce-description="">
  <div class="left col-lg-6 col-md-6 col-sm-12 col-xs-12 primary-brand-color">
 <h2 class="headline primary-brand-color"> FINANCIAL ASSISTANCE IS AVAILABLE FOR JADENU </h2>  <div class="content"> <p>You may be eligible for immediate co-pay savings on your next prescription of JADENU:</p>
<ul>
<li>Eligible patients with private insurance may pay $0 per month</li>
<li>Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*</li>
</ul> </div> 
 <a href="http://www.copay.novartisoncology.com/eligibility/?name=jadenu" class="coPayAnchor primary-brand-color-border">
  <figure class="primary-brand-color">
<img class="svg" src="../../modules/DigiOne.Products/Client/Static/Images/Icons/icon_externalLink.svg" />
  </figure>
  <span class="primary-brand-color">See if you’re eligible</span>
 </a>
  </div>
  <div class="right col-lg-6 col-md-6 col-sm-12 col-xs-12">
 <div class="imgOrVideo"> 


<div id="onco-image-block-56444" class="onco-image-block full-width-view  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 " data-hvce="" data-hvce-description="">
 <style>
		#onco-image-block-56444 .desktopImg {
			display: block;
		}

  #onco-image-block-56444 .tabletImg, #onco-image-block-56444 .mobileImg {
			display: none;
		}

#onco-image-block-56444 div.zoom-mobile {
			display: none;
		}


@media screen and (max-width: 767px) { #onco-image-block-56444 div.zoom-desktop,  #onco-image-block-56444 div.zoom-tablet { display: none; }  #onco-image-block-56444 div.zoom-mobile {display: block;}}
 </style>

 <div class="inner">

<div class="image">
 <img class="img-responsive desktopImg" src="../../globalassets/products/jadenu/images/patient-support/onc-1214791_ucp-patient-card.jpg" />


</div>
 </div>
</div> </div></div>
 </div>





<div id="detail-page-content-block-243294" class="products-detailed-content-block  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">



<p style="font-size: 80%;">* Limitations apply. This offer is only available to patients with private insurance. The program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, visit <a href="https://www.copay.novartisoncology.com/?name=jadenu" target="_blank">Copay.NovartisOncology.com</a> or call <a href="tel:18775777756">1-877-577-7756</a>.</p>
<p>&nbsp;</p>
<p>To find out if you are eligible for the Universal Co-pay Program, call <a href="tel:18775777756">1-877-577-7756</a> or visit <a href="https://www.copay.novartisoncology.com/?name=jadenu" target="_blank">Copay.NovartisOncology.com</a>.</p>

 </div>
</div>




<div id="detail-page-content-block-121720" class="products-detailed-content-block  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">

<h3 class="title primary-brand-color">PATIENT ASSISTANCE NOW ONCOLOGY (PANO)</h3>


<h3><img class="img-responsive" alt="PANO logo" src="../../globalassets/products/jadenu/images/pano-logo.png" height="87" width="320" /></h3>
<p>&nbsp;</p>
<p>Our Patient Assistance Now Oncology (PANO) program was created to assist you with accessing your Novartis medicine(s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.</p>
<p>&nbsp;</p>
<p><strong>Program overview</strong></p>
<p>Novartis Oncology is committed to helping you get the Novartis medicine(s) you need. Access to medicine(s) can sometimes be difficult or confusing. PANO offers resources and support designed specifically to help make that process easier.*</p>
<p>&nbsp;</p>
<p>PANO can offer the following services:</p>
<ul>
<li>Help with understanding your insurance coverage and financial responsibilities throughout the insurance verification process</li>
<li>Aid with identifying the pharmacies covered by your insurance plan</li>
<li>Insurance and Medicare education</li>
<li>Information about financial assistance that may be available</li>
<li>Patient Support Counselors who are able to provide information in more than 160 languages</li>
<li>One single point of contact to help guide you through getting access to the Novartis medicine(s) prescribed by your doctor</li>
</ul>
<p style="font-size: 80%;">*Novartis Pharmaceuticals Corporation does not guarantee success in obtaining reimbursement or financial assistance. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved.</p>
<p>&nbsp;</p>
<p>To learn more, call <a href="tel:18002827630">1-800-282-7630</a> or visit <a href="http://www.Patient.NovartisOncology.com" target="_blank">Patient.NovartisOncology.com</a></p>
<p>&nbsp;</p>

 </div>
</div>






<div id="product-callout-block-16987" class="product-callout-block  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <a href="../download-helpful-materials/index.html"  data-hvce="" data-hvce-description="">
  <div class="wrapper">
<div class="icon">
 <img src="../../globalassets/global-images47/fixed_callout_icons_8/icon_fixedcallout_info.png" alt="Icon Resources & Support" /> </div>
<div class="text">
 <div class="title primary-brand-color"> Resources & Support </div>
  <div class="description"><p> Understand JADENU resources and support<span class="secondary-brand-color glyphicon glyphicon-menu-right" aria-hidden="true"></span> </p></div>
</div>
  </div>
 </a>
</div>







<div id="product-callout-block-409095" class="product-callout-block  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <a href="../frequently-asked-questions/index.html"  data-hvce="" data-hvce-description="">
  <div class="wrapper">
<div class="icon">
 <img src="../../globalassets/global-images47/fixed_callout_icons_8/icon_fixedcallout_looking-for-information.png" alt="Icon Questions about Jadenu?" /> </div>
<div class="text">
 <div class="title primary-brand-color"> Questions about Jadenu? </div>
  <div class="description"><p> Review frequently asked questions<span class="secondary-brand-color glyphicon glyphicon-menu-right" aria-hidden="true"></span> </p></div>
</div>
  </div>
 </a>
</div>


 <div class="next-page-block  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
  <div class="inner">
<div class="next-page">
 <a href="../frequently-asked-questions/index.html">Next: Frequently Asked Questions <span class="secondary-brand-color glyphicon glyphicon-menu-right" aria-hidden="true"></span></a>
</div>
  </div>
 </div>
 </div>
</div>
  </div>
 </div>
  </main>

<footer class="row gc-contentbottom">
 <div class="container">
  <div id="" class="block-rich-text  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">
  <p><strong class="primary-brand-color">INDICATION</strong></p>
<p><strong class="primary-brand-color">Treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron&nbsp;Overload)</strong></p>
<p>JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle&nbsp;(deferasirox) granules are indicated for the treatment of chronically elevated levels of iron in the blood caused by repeated blood transfusions (transfusional hemosiderosis) in patients 2&nbsp;years of age and&nbsp;older.</p>
<p><strong class="primary-brand-color">Limitation on the Use of JADENU</strong></p>
<p>It is not known if JADENU is safe or effective when taken with another therapy that lowers iron levels in the&nbsp;blood.</p>
<p><strong class="primary-brand-color">IMPORTANT SAFETY INFORMATION for JADENU<sup>®</sup>&nbsp;(deferasirox) tablets for oral use and JADENU<sup>®</sup>&nbsp;Sprinkle&nbsp;(deferasirox) granules</strong></p>
<div style="border: solid 1px #000; padding: 1em 1em 0 1em !important; margin-bottom: 2em;">
<p><strong>What is the most important safety information to know about JADENU?</strong></p>
<p><strong>JADENU contains deferasirox, the same active ingredient in EXJADE<sup>®</sup> (deferasirox) tablets for oral suspension. Deferasirox may cause serious kidney problems, liver problems, and bleeding in the stomach or intestines. In some cases, these problems were fatal. Kidney problems occurred particularly in patients with multiple medical conditions and those who were very ill because of their disease. Bleeding in the stomach or intestines occurred more often in elderly patients. Liver problems were more likely to happen in patients older than 55 years.&nbsp;</strong></p>
<p><strong>Your doctor should check your kidney function with blood tests and urinalyses:</strong></p>
<ul>
<li><strong>Before taking JADENU </strong></li>
<li><strong>Monthly during treatment </strong></li>
</ul>
<p><strong>If you already have a history of kidney problems or are at risk for kidney problems, your doctor should check your&nbsp;kidneys:</strong></p>
<ul>
<li><strong>Every week for the first&nbsp;month </strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
<p><strong>Your doctor should check your liver function with blood tests:</strong></p>
<ul>
<li><strong>Before taking JADENU </strong></li>
<li><strong>Every other week for the first month after starting&nbsp;JADENU </strong></li>
<li><strong>Monthly during treatment</strong></li>
</ul>
</div>
<p><strong class="primary-brand-color">You should not take JADENU if you&nbsp;have:</strong></p>
<ul>
<li>Certain kinds of kidney problems</li>
<li>Preexisting severe liver problems</li>
<li>High-risk myelodysplastic syndromes (MDS)</li>
<li>Advanced cancer</li>
<li>Low blood counts (low platelets)</li>
<li>An allergy to JADENU or any ingredient of&nbsp;JADENU</li>
</ul>
<p><strong class="primary-brand-color">Additional Important Safety Information</strong></p>
<p><strong class="primary-brand-color">Kidneys</strong></p>
<ul>
<li>If you have a preexisting kidney condition, are elderly, have multiple medical conditions, or are taking medicine that affects your kidneys, you are at increased risk of complications. Your doctor will do blood tests (serum creatinine and/or creatinine clearance, estimated glomerular filtration rate (eGFR), and serum electrolytes) every week for the first month you are taking JADENU or if your dose has changed, and then every month after that. Your doctor may adjust your dose based on the results of these&nbsp;tests</li>
<li>Your doctor will also collect urine samples&nbsp;monthly</li>
<li>Some patients developed severe kidney problems while taking deferasirox, in some cases fatal, and in some cases requiring dialysis. Most of the fatalities occurred in patients who were very ill because of their&nbsp;disease</li>
</ul>
<p>In younger patients, stop taking JADENU during serious illnesses that can cause dehydration such as vomiting, diarrhea, or prolonged decreased oral intake.</p>
<p><strong class="primary-brand-color">Liver</strong></p>
<ul>
<li>If you have a preexisting severe liver problem, you should not use&nbsp;JADENU</li>
<li>If you have mild or moderate liver problems, your doctor will do blood tests (serum transaminases and bilirubin) before starting treatment, every 2 weeks during the first month of treatment, and then monthly. Your doctor may adjust your dose based on the results of these&nbsp;tests</li>
<li>Some patients developed severe liver problems, in some cases fatal, while taking deferasirox. Many of these patients were older than 55&nbsp;years of age and/or had multiple medical conditions already affecting their&nbsp;liver</li>
</ul>
<p><strong class="primary-brand-color">Bleeding in the Stomach or Intestines</strong></p>
<ul>
<li>Some patients developed stomach irritation or bleeds while taking deferasirox. In some cases, stomach bleeds were fatal, usually in patients who were elderly and had preexisting blood cancers and/or low blood counts (low&nbsp;platelets)</li>
<li>Talk to your doctor if you are taking other drugs that can also irritate your stomach or cause a stomach bleed (eg,&nbsp;pain&nbsp;relievers/anti-inflammatory drugs, corticosteroids, oral bisphosphonates, or blood&nbsp;thinners)</li>
</ul>
<p><strong class="primary-brand-color">Blood Disorders</strong></p>
<ul>
<li>Some patients developed severe blood disorders, in some cases fatal, while on deferasirox therapy.<br />Having a preexisting blood disorder may increase the risk</li>
<li>Your doctor will do a blood test to check your blood&nbsp;counts</li>
</ul>
<p><strong class="primary-brand-color">Increased Risks With Different Ages</strong></p>
<ul>
<li><em>Elderly Patients</em>: Since deferasirox has been on the market, there have been reports of serious reactions, sometimes leading to death. These serious reactions and deaths have happened most often when deferasirox was taken by elderly&nbsp;patients</li>
<li><em>Pediatric Patients</em>: Serious and fatal events have occurred in pediatric patients. These were associated with dehydration or when dosing is continued as the iron burden is in the range of normal</li>
</ul>
<p><strong class="primary-brand-color">Allergic Reactions</strong></p>
<ul>
<li>Serious allergic reactions (which include swelling of the throat) have been reported in patients taking deferasirox, usually within the first month of&nbsp;treatment</li>
<li>If you develop swelling of the throat, a severe rash, hearing problems, or vision disturbances, stop taking JADENU and contact your doctor&nbsp;immediately</li>
</ul>
<p><strong class="primary-brand-color">Severe Skin Reactions</strong></p>
<ul>
<li>Severe skin disorders that result in a very serious rash, called Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme have been reported during treatment with deferasirox. Other skin reactions including DRESS (drug reaction with eosinophilia and systemic symptoms) can also occur. If you develop a severe rash, stop taking JADENU and contact your doctor&nbsp;immediately</li>
<li>Mild to moderate skin rashes may occur during treatment with deferasirox. Let your doctor know if the rash doesn’t go away on its own or gets worse. Your doctor may need to change your dose of&nbsp;JADENU</li>
</ul>
<p><strong class="primary-brand-color">Hearing and Vision Changes</strong></p>
<ul>
<li>Changes to hearing and vision have been reported in patients taking deferasirox. If you notice changes in your hearing or eyesight, contact your doctor&nbsp;immediately</li>
<li>You may also receive a hearing or vision test prior to receiving JADENU, and yearly thereafter. Your doctor may change your dose based on the results of these&nbsp;tests</li>
</ul>
<p><strong class="primary-brand-color">Common Side Effects</strong></p>
<ul>
<li>The most commonly reported side effects related to deferasirox in clinical trials were mainly nausea, vomiting, diarrhea, stomach pain, increases in kidney laboratory values, and skin&nbsp;rash</li>
<li>Let your doctor know if you are experiencing any side effects. Your doctor may need to change your&nbsp;dose</li>
<li>If you experience diarrhea or vomiting, you must continue to drink&nbsp;fluids</li>
<li>You are encouraged to report negative side effects of prescription drugs to the FDA. Visit<strong>&nbsp;<a href="http://www.fda.gov/medwatch" target="_blank" rel="nofollow" data-target="#interstitialPopUp">www.fda.gov/medwatch</a></strong>,<span>&nbsp;or call&nbsp;<a class="primary-brand-color" href="tel:1-800-332-1088">1-800-FDA-1088</a></span></li>
</ul>
<p><strong class="primary-brand-color">Taking Other Medicines With&nbsp;JADENU</strong></p>
<ul>
<li>If you are taking other medicines, such as birth control pills, diabetes drugs, seizure drugs, cholesterol-lowering drugs, or medicine for serious illnesses, talk to your doctor. JADENU may affect how these drugs&nbsp;work</li>
</ul>
<p>Talk to your doctor to determine if prescription JADENU therapy is right for&nbsp;you.</p>
<p><strong class="primary-brand-color"><a title="Please see full Prescribing Information, including Boxed WARNING, for JADENU (deferasirox)." href="https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/jadenu.pdf" target="_blank">Please see full Prescribing Information, including Boxed WARNING, for JADENU<sup>®</sup> (deferasirox) tablets for oral use and JADENU<sup>®</sup> Sprinkle (deferasirox) granules. </a></strong></p>
 </div>
</div>
 </div>
</footer>

  <div class="row gc-subFooter">
<div id="back-to-top-id" class="visible-xs back-to-top">
 <div class="inner">
  <p><a href="index.html#">Back to Top</a></p>
 </div>
</div>
  </div>

<div class="row gc-footer">
 <div class="container">
  



<div class="footer-block  col-lg-12 col-md-12 col-sm-12 col-xs-12 col-lg-offset-0  col-md-offset-0 col-sm-offset-0  col-xs-offset-0 ">
 <div class="inner">

  <div class="social-network-links">








  </div>


  <div class="footer-links">
<div><div><div id="" class="block-rich-text  ">
 <div class="inner">
  <ul>
<li><a href="https://www.pharma.us.novartis.com/utils/contact/info/emaili" target="_blank" rel="nofollow" data-target="none">Contact Us</a></li>
<li><a href="http://www.exjade.com/" target="_blank" rel="nofollow" data-target="none">Non-US Residents</a></li>
<li><a href="../../sitemap/index.html" data-target="none">Sitemap</a></li>
</ul>
 </div>
</div></div></div>
  </div>



  <a href="https://www.pharma.us.novartis.com/about-us" target="_blank">
<div class="logo-image">
 <img src="../../globalassets/global-images47/images/novartis-logo_patient-sites-01.jpg" />
</div>
  </a>



  <div class="disclaimer-content">
<p>Use of website is governed by the <a href="https://www.pharma.us.novartis.com/terms-use" target="_blank">Terms of Use</a> and <a href="https://www.pharma.us.novartis.com/privacy-policy" target="_blank">Privacy Policy</a>.</p>
<p>Copyright © 2019 <a href="https://www.pharma.us.novartis.com/about-us" target="_blank">Novartis Pharmaceuticals&nbsp;Corporation</a>. <span style="white-space: nowrap;">All rights reserved.</span></p>
  </div>

<div class="omap-block ">
 9/19 JAD-1220189
</div>

 </div>
</div>

 </div>
</div>

 </div>



 <div id="interstitialPopUp" class="modal fade">
  <div class="modal-dialog">
<div class="modal-content">
 <div class="modal-header">
  <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
  <img class="center-block new-logo" src="../../modules/DigiOne.Oncology.Library/Client/Static/Images/Disclaimer/new-novartis-logo.svg" />
 </div>
 <div class="modal-body">
  <p>You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.</p>
 </div>
 <div class="modal-footer">
  <div class="text-center">
<a class="btn btn-default btn-cancel" data-dismiss="modal"><span>Cancel</span></a>
<a class="btn btn-continue interstitialOKButton" id="" href="index.html#">OK</a>
  </div>
<div class="disclaimer-omap">
 1/17  ONC-1154329
</div>
 </div>
</div>
  </div>
 </div>


 <script src="../../DigiOne/Framework/Scripts%3Fv=0Aoha4AtAfYZ-9hPy9VQzPrJcWpnTOAHNq2dWP4Kxo81"></script>

 <script src="../../DigiOne.Oncology.Library/Scripts%3Fv=VT4Of4e05DGBbHQI5ZdYVRU6EEgHpvVoZ37PSc3_Rmo1"></script>


<script src="../../DigiOne.Theme.Products/Scripts%3Fv=GlzO1uOYTuDU9qSqk16NYUjzpmGd2OkiiPt77PEp-8k1"></script>
 <!--[if lt IE 9]>HTML5Shiv
  <script src="/DigiOne/Framework/IE9?v=1EEuAt300Hg97w2gE2PA4YWTT0kVLu7pfFlF_WVaVmg1"></script>

 <![endif]-->
 <!--[if gte IE 9]>
  <style type="text/css">.gradient {
filter: none;
  }
  </style>
 <![endif]-->
 <!--[if (gte IE 8)&(lt IE 10)]>
  <script src="/DigiOne/Framework/IE9_10?v=i7EUGOpYfvmWvcv2-EZoKEjPsyzodyLzyYS4-j7or201"></script>

 <![endif]-->
 <script src="../../DependencyHandler.axd/9faede5d701d5a6ccddc9955a3fe7a69/1/js" type="text/javascript"></script>



<script>
 var brandName = "Jadenu";

 var dataLayer = dataLayer || {};

 // global vars
 var path = window.location.pathname.split('/'),
 pageName,
 channel,
 brandProduct,
 campaign;

 // set pageName var
 var hasEndSlash = (window.location.pathname.lastIndexOf('/') == window.location.pathname.length - 1);
 if (hasEndSlash) {
  if (path[path.length - 1] == "") {
path.pop();
  }
 }
 path = path.slice(1);
 pageName = path.join(':').toLowerCase();
 pageName = path.length == 0 ? 'patient:products:' + brandName : 'patient:products:' + brandName + ':' + pageName;

 var formResult = '',
  formName = '';


 // build dataLayer var
 dataLayer = {
  page: {
pageName: pageName,
pageCategory: 'Patient'
  }
 };

 // 

 if ($('.ffb-component-form-container').length > 0) {
  var formLabel = brandName;
  formName = formLabel + ':receive-updates-about-' + brandName;
  dataLayer.page.formName = formName;

  $(document).ajaxComplete(function() {

// triggered on continue click
// only present on form steps
$("#ffb-form-step-index").click();

// only defined on submit
if ($('.ffb-component-form-container-success').length > 0) {
 $("input[name='__RequestVerificationToken']").click();
 // triggered on form success
 // Adobe DTM 'HVCE 2 Day 10' event tule
 $("#successPageHr").click();
 
} else if ($('.ffb-component-form-container-duplicate').length > 0) {
 $("input[name='__RequestVerificationToken']").click();
 // triggered on form success
 // Adobe DTM 'HVCE 2 Day 10' event tule

} else if ($('.ffb-component-form-container-failure').length > 0) {
 $("input[name='__RequestVerificationToken']").click();
 // triggered on form success
 // Adobe DTM 'HVCE 2 Day 10' event tule
}
// triggered on form submitted
// Adobe DTM 'Form Success' event tule
  });
 }

 $(document).ready(function() {
  /*
  *  Set fileDownload and exitLink vars if clicks on such links
  */
  function isExternalLink(href) {
var dataTarget = $(this).data('target');
var domain = href.split("?");
return domain[0].indexOf('http') != -1 &&
 domain[0].indexOf(window.location.hostname) == -1 &&
 dataTarget != "none";
  }

  // fileDownload links
  $('body').on('click', 'a',
function() {
 var $this = $(this);

 if (typeof $this.attr('href') != "undefined") {

  var href = $this.attr('href');

  if ($this.parents('.selectpicker').length == 0) {

if (isExternalLink(href)) {
 dataLayer.page.exitLink = href;
}

var pattern = /^.*\.(docx|DOCX|xlsx|XLSX|xls|doc|DOC|pdf|PDF)$/;
var ext = href.match(pattern);

if (ext != null) {
 dataLayer.page.fileDownload = href;
}
  }
 }
});
  });

 /*
  *  Edit: This file is not intended to be loaded in the solution, that's why it's not located in /Scripts. It's
  *  intended to be uploaded in the admin in the "Links to js files" property in the homepage of the brand website
  *  you want to have the Adobe Tracking implemented.
  * 
  *  => Upload it after "AdobeTrackingDB.js" as it's need to be executed after.
  */
 try {
  _satellite.pageBottom();
 } catch (error) {}
</script>


</body>
</html>
